Halozyme
HALO
674 hedge funds and large institutions have $9.62B invested in Halozyme in 2026 Q2 according to their latest regulatory filings, with 108 funds opening new positions, 271 increasing their positions, 207 reducing their positions, and 66 closing their positions.
69% more call options, than puts
Call options by funds: $39.6M | Put options by funds: $23.4M
64% more first-time investments, than exits
New positions opened: 108 | Existing positions closed: 66
31% more repeat investments, than reductions
Existing positions increased: 271 | Existing positions reduced: 207
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
24% more capital invested
Capital invested by funds: $7.79B → $9.62B (+$1.83B)
6% more funds holding
Funds holding: 637 → 674 (+37)
2.25% more ownership
Funds ownership: 101.68% → 103.92% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Los Angeles Capital Management
Los Angeles,
California
|
+$85.1M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$66.6M |
| 3 |
MMC
Mizuho Markets Cayman
Grand Cayman,
Cayman Islands
|
+$56.9M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$39.4M |
| 5 |
Goldman Sachs
New York
|
+$36.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$103M |
| 2 |
MMA
Mizuho Markets Americas
New York
|
-$63.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$56.9M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$56.4M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$32.2M |
HALO Hedge Fund Activity: Q2 2026 in Review
674 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q2 2026, worth a combined $9.62B — up 24% from $7.79B a quarter earlier.
Buyers outnumbered sellers: 108 funds opened new HALO positions and 66 closed out — a net gain of 42 holders — while 271 added to existing stakes and 207 trimmed.
The largest buyer was Los Angeles Capital Management, adding an estimated $85.1M. The largest seller was Jupiter Asset Management, cutting an estimated $103M.
- 674 institutional investors held Halozyme (HALO) as of Q2 2026, up from 637 in Q1 2026.
- Funds reported $9.62B of Halozyme stock for Q2 2026, up 24% quarter-over-quarter.
- 108 funds opened new Halozyme positions in Q2 2026 and 66 closed out, a net change of +42 holders.
- The largest Halozyme buyer in Q2 2026 was Los Angeles Capital Management, an estimated $85.1M added.
- The largest Halozyme seller in Q2 2026 was Jupiter Asset Management, an estimated $103M sold.
Based on aggregated 13F filings for Q2 2026.